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Doxycycline hyclate (DOX), chemically known as (4S,4aR,5S,5aR,6R,12aS)-4-(di-
methylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahyd-
rotetracene-2-carboxamide hydrochloride hemiethanol hemihydrate (Fig. 1), is one of
the tetracycline derivatives, which has a wide range of antibacterial activities. DOX is
frequently used to treat chronic prostatitis, sinusitis, syphilis, chlamydia, pelvic inflam-
matory disease, acne, rosacea, and rickettsial infections.
The drug is official in British Pharmacopoeia (1), which describes the HPLC method
for the determination of DOX either in raw material or in pharmaceutical formulations.
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A spectrophotometric method for the determination of
doxycycline (DOX) is described. The method is based on
the formation of blue colored chromogen due to reduc-
tion of tungstate and/or molybdate in Folin-Ciocalteu
(F-C) reagent by DOX in alkaline medium. The colored
species has an absorption maximum at 770 nm and the
system obeys Beer’s law over the concentration range
0.75–12.0 mg mL–1 DOX. The apparent molar absorptivi-
ty is 2.78 ´ 104 L mol–1 cm–1. The limit of quantification
and detection values are reported to be 0.20 and 0.08 mg
mL–1, respectively. Over the linear range applicable, the
accuracy and precision of the method were evaluated on
intra-day and inter-day basis. The reported mean accu-
racy value was 101.0 ± 1.7 %, the relative error was  2.7
% and the relative standard deviation was  2.5 %. Ap-
plication of the proposed method to bulk powder and
commercial pharmaceutical tablets is also presented. No
significant difference was obtained between the results
of the proposed method and the official BP method. The
procedure described in this paper is simple, rapid, accu-
rate and precise.
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The literature contains several methods for the determination of DOX in pharmaceutical
dosage forms, including liquid chromatography (2), sequential injection chromatography
(3) and capillary electrophoresis (4). A few visible spectrophotometric methods based on
the different reaction schemes are found in the literature for the assay of DOX. These in-
clude FIA-spectrophotometry with copper carbonate (5) and spectrophotometry based
on colour reactions with thorium(IV) (6), sodium cobaltnitrite (7) and uranyl acetate (8).
Besides, kinetic spectrophotometry using Cu(II)/H2O2 (9) and multivariate calibration
method (10) have also been reported by different authors.
Chromatographic techniques are the most widely used ones. Although these proce-
dures are specific, most of the described methods are time consuming and require multi-
stage extraction procedures. On the other hand, the reported spectrophotometric methods
(5–10) are for different reasons not satisfactory for the routine quality assurance. Some of
these methods suffer from disadvantages such as poor sensitivity, low stability of the
species, use of organic solvent, scrupulous control of experimental variables and special
equipment (Table VII).
Folin-Ciocalteu reagent (F-C) is widely used in the area of plant biology for analysis
of polyphenols (11) and for the determination of many phenolic compounds in pharma-
ceuticals (12, 13) based on Folin-Ciocalteu reagent reduction. The present paper descri-
bes a reduction reaction involving F-C reagent and DOX resulting in the formation of a
blue chromogen that could be measured at 770 nm.
EXPERIMENTAL
Instrument
A Systronic model 106 digital spectrophotometer (Systronics Ltd, India) with mat-
ched 1-cm quartz cells was used for absorbance measurements.
Chemicals and reagents
Chemicals used were of analytical grade. Distilled water was used throughout the
investigation.
Folin-Ciocalteu reagent (Merck, India), sodium carbonate (S.D. Fine Chem Ltd, In-
dia) were of analytical reagent grade and used without further purification. A pure DOX
(pharmaceutical grade) sample was kindly provided by Lotus Pharma Ltd, India. Three
brands of tablets, namely, DOX-T 100 (Dr. Reddy’s Lab, India), Microdox-DT and Doxy
100 (both from Micro Labs Ltd, India) were obtained from commercial sources.
446
P. J. Ramesh et al.: Sensitive and selective spectrophotometric assay of doxycycline hyclate in pharmaceuticals using Folin-Ciocalteu
reagent, Acta Pharm. 60 (2010) 445–454.
O
OH
CONH2
NOH
O OHOH
H H
OH
HCl, ½ C2H6O, ½ H2O
Fig. 1. Structure of doxycycline (DOX).
Drug and reagent solutions
A stock solution of DOX (300 mg mL–1) was prepared by dissolving pure DOX in
water in a volumetric flask. Working concentration of DOX (30 mg mL–1) was prepared
by dilution of the above stock solution with water.
The commercially available F-C reagent (defined as 2 eq L–1) was diluted with wa-
ter in a ratio 1:1.
Absorption spectra
Pure DOX solution equivalent to 8.0 mg mL–1 was mixed with 3 mL of 1.4 mol L–1
Na2CO3 and 2 mL of F-C reagent (1:1) in a 10-mL volumetric flask. After 20 min, the vol-
ume was made up to the mark with water and the content was mixed throughly. A
blank solution was prepared in the same way in the absence of DOX. The blank was
measured against water. Maximum absorbance was obtained at 770 nm and was fixed as
analytical wavelength.
General analytical procedure
Different aliquots of the working standard DOX solution (30 mg mL–1), ranging
from 0–4.0 mL, were transferred into a series of 10-mL volumetric flasks and the total
volume was brought to 4.0 mL with water. To each flask, 3.0 mL of 1.42 mol L–1 Na2CO3
and 2.0 mL of F-C reagent (1:1) solution were successively added by means of a micro-
burette. The flasks were stoppered, contents were mixed and kept at room temperature
for 20 min. The volume was made up to the mark with water and the absorbance of each
solution was measured at 770 nm against a reagent blank.
Assay procedure for tablets
An amount of finely ground tablet powder equivalent to 3.0 mg of DOX was accu-
rately weighed into a 100-mL volumetric flask, the flask was shaken after addition of a
70 mL of water for about 20 min and finally the volume was made up to the mark with
water. The content was kept aside for 5 min, and filtered using Whatman No. 42 filter
paper. The first 10-mL portion of the filtrate was discarded and a suitable aliquot was
used for the assay as described under »General analytical procedure«.
Validation
Precision and accuracy. – For 3.0, 6.0 and 9.0 mg mL–1 of DOX, the assay described un-
der the general analytical procedure was repeated seven times within a day to deter-
mine the repeatability (intra-day precision) and five times on different days to determine
the intermediate precision (inter-day precision) of the method. Percentage relative error
was evaluated between the measured mean concentration and the taken DOX concen-
tration.
Recovery experiment was performed by applying the standard-addition technique.
The recovery was assessed by determining the agreement between the measured con-
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centration and the added known concentration to the sample. The test was done by
spiking the pre-analyzed tablet powder (4.16 mg mL–1) with pure DOX at three different
levels (2.5, 5.0 and 7.5 mg mL–1) and the total was found by the proposed method. Each
test was repeated three times.
Limits of detection (LOD) and quantification (LOQ). – The limits of detection (LOD)
and quantification (LOQ) were calculated according to ICH guidelines (14) using the for-
mulae:
LOD = 3.3 SD/b and LOQ = 10 SD/b, where SD is the standard deviation of blank
absorbance values (n = 6), and b is the slope of the calibration line.
Selectivity. – A placebo blank of the composition: starch (10 mg), acacia (15 mg), hy-
droxyl cellulose (10 mg), sodium citrate (10 mg), talc (20 mg), magnesium stearate (15
mg) and sodium alginate (10 mg) was made and its extract was prepared as described
under the assay procedure for tablets and then subjected to analysis.
To assess the role of inactive ingredients on the assay of DOX, the general procedure
was followed by taking 4, 6 and 8 mg mL–1 DOX solution prepared using a synthetic
mixture.
RESULTS AND DISCUSSION
The structural features of DOX allowed the use of F-C reagent for its assay. The pro-
posed method is based on the formation of a blue colored chromogen when DOX re-
acted with the F-C reagent in the presence of sodium carbonate. Colour formation may
be explained as follows based on the analogy reported by Peterson (15). Mixed acids in
the F-C reagent involve the following chemical species:
3H2O·P2O5·13WO3·5MoO3·10H2O and 3H2O·P2O5·14WO3·4MoO3·10H2O
DOX probably causes a reduction of molybdate in the F-C reagent, thereby produc-
ing one or more reduced species that have a characteristic intense blue colour.
Fig. 2 shows the absorption spectra of the reaction product and reagent blank; un-
der the same experimental conditions the blank had negligible absorbance.
Method development
Optimum conditions were fixed by varying one parameter at a time while keeping
other parameters constant and observing their effect on the absorbance at 770 nm.
To find a suitable medium for the reaction different aqueous bases were investiga-
ted. Best results were obtained with sodium carbonate. It was found that maximum and
constant absorbance was obtained in the concentration range of 0.28–0.57 mol L–1
Na2CO3, thus 0.43 mol L–1 was fixed as optimal.
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It is apparent that ten to twenty-fold diluted F-C reagent produced maximum color
intensity; F-C reagent at a dilution level of 1:20 was actually present in the reaction mix-
ture.
The reaction time was studied by measuring the absorbance of the blue chromogen
after mixing the reactants over a period from 2 min to 2 h. Maximum colour developed
in 20 min and was stable for at least 60 min thereafter. Measurements were therefore
made only after 20 min throughout the investigation.
Highest sensitivity was achieved when the order of reactants addition was maintai-
ned as described in the general analytical procedure and the same was followed throu-
ghout the investigation.
Validation
A linear correlation was found between absorbance at lmax and DOX concentration
in the range 0.75–12.0 mg mL–1. Linear regression parameters within the Beer’s law lim-
its and molar absorptivity values of the method are given in Table I. Log absorbance ver-
sus log concentration plot yielded a straight line with the slope equal to 0.9922.
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Fig. 2. Absorption spectra of: a) reaction
product of DOX (8.0 mg mL–1) with F-C
reagent in Na2CO3 solution, b) blank.
Table I. Sensitivity and regression parameters
Parameter Value
l (nm) 770
Linear range (mg mL–1) 0.75–12.0
Molar absorptivity (e) (L mol–1 cm–1) 2.78 ´ 104
Limit of detection (LOD) (mg mL–1) 0.08
Limit of quantification (LOQ) (mg mL–1) 0.20
Regression equation, Y = aX+b:
intercept (a) ± SDa 0.0054 ± 0.0051
slope (b) ± SDb 0.0531 ± 0.0006
Regression coefficient (R) 0.9997
X: DOX (mg mL–1).
The percentage relative standard deviation values were  1.6 % (intra-day) and  2.5 %
(inter-day), indicating high precision of the method. Percent relative error of  2.7 % was
evaluated. Results are summarized in Table II.
The percentage recovery values obtained were in the range from 98.9 to 103.6 %,
with relative standard deviation 0.6–1.3 %. In all the cases, the results showed a fairly
good accuracy of the method (Table III).
A systematic study was performed to determine the effect of the matrix by analyz-
ing the placebo blank. In the analysis of the placebo blank solution, the absorbance in
each case was equal to the absorbance of reagent blank which revealed no interference.
The recovery values obtained in this study are presented in Table IV. The values of
97.4–104.3 % with RSD values of < 3 % clearly indicate non-interference of inactive in-
gredients in the assay.
In order to check the robustness of the method, the assay was performed using the
same operational conditions but using different instruments in two different laborato-
ries, different analysts and different elapsed times. The results obtained from inter-lab,
inter-day and inter-analyst assays were reproducible. The inter-analyst RSD were within
2.5 % whereas the inter-instrument and inter-lab RSDs for the same DOX concentration
were less than about 2.6 %. The results are presented in Table V.
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Table II. Evaluation of intra-day and inter-day error and precision
DOX taken
(mg mL–1)
Intra-day (n = 7) Inter-day (n = 5)
DOX found ± CL
(mg mL–1)
eR (%) RSD (%)
DOX found ± CL
(mg mL–1)
eR (%) RSD (%)
3.00 2.95 ± 0.04 1.7 1.6 3.08 ± 0.08 2.7 2.1
6.00 6.06 ± 0.06 1.0 1.0 6.10 ± 0.19 1.7 2.5
9.00 9.08 ± 0.07 0.9 0.9 9.12 ± 0.22 1.3 2.0
CL – confidence limits calculated from: CL = ± tSD/ n.
Table III. Recovery study by the standard addition method
Tablet studied
DOX in tablet extract
(mg mL–1)
Pure DOX added
(mg mL–1)
DOX recovered
(%)a
DOX 100
4.16
4.16
4.16
2.50
5.00
7.50
98.9 ± 1.0
100.1 ± 0.9
102.3 ± 1.2
DOXY 100
4.16
4.16
4.16
2.50
5.00
7.50
99.6 ± 0.6
101.2 ± 1.3
103.6 ± 1.4
a Mean ± SD, n = 3.
Analysis of pharmaceutical formulations
The described procedure was successfully applied to the determination of DOX in
pharmaceutical formulations. The results obtained were statistically compared with the
official BP method (1). The official method is liquid chromatography of DOX with UV
detection at 350 nm. The results obtained by the proposed method agreed well with
those of the reference method. The results were also compared statistically using Stu-
dent’s t-test for accuracy and a variance F-test for precision with those of the reference
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Table V. Intermediate precision of the method
DOX taken
(mg mL–1)
RSD (%)
Inter-labs
(n = 4)
Inter-analysts
(n = 4)
Inter-instruments
(n = 4)
3.00 1.6 2.1 2.5
6.00 2.1 2.0 2.3
9.00 2.5 2.5 2.6
Table VI. Analysis of tablets by the proposed method and the reference method
Tablet brand
name
DOX taken
(mg mL–1)
Found ± SD
Student’s
t-value
Variance ratio
F-valueReference
methoda
Proposed
methoda
DOX-T 100
6.00 5.99 ± 0.03 5.97 ± 0.03 1.05 1.00
9.00 8.94 ± 0.07 9.01 ± 0.04 2.01 3.06
DOXY 100
6.00 5.97 ± 0.03 5.96 ± 0.03 0.53 1.00
9.00 8.96 ± 0.05 9.05 ± 0.06 2.59 1.44
Microdox-DT
100
6.00 5.97 ± 0.02 5.94 ± 0.04 1.58 4.00
9.00 9.03 ± 0.04 8.94 ± 0.07 2.59 3.06
a Mean ± SD, n = 5.
Tabulated t-value at the 95 % confidence level is 2.77; tabulated F-value at the 95 % confidence level is 6.39.
Table IV. Selectivity studya
DOX taken (mg mL–1) DOX recovered (%)b
4.00 98.3 ± 1.3
6.00 97.4 ± 2.2
8.00 104.3 ± 2.9
a Synthetic mixture of DOX in placebo blank.
b Mean ± SD, n = 3.
method at 95 % confidence level. The results showed that the calculated t-and F-values
did not exceed the tabulated values, inferring that the proposed method is as accurate
and as precise as the reference method. The results are shown in Table VI. The favour-
able accuracy and RSD values of the new method harmonize well with the previous val-
idation data.
The proposed method was found to be superior to the reported methods with re-
spect to speed, simplicity, sensitivity and cost-effectiveness. It is less costly and it does
not require expensive equipment, high-cost reagents or specialized technicians. In addi-
tion, it is free from extreme experimental or stringent conditions like heating at high
temperature or extraction procedure (for comparasion see Table VII).
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Table VII. Comparison of performance characteristics of the proposed method with the published method
Reagent/s used Methodology
lmax
(nm)
Linear
range
LOQ/LOD
(mg mL–1)
Remarks Ref.
Copper
carbonate
Complex colour
measured
395
10.0–80.0
mg mL–1
NA
FIA assembly,
less sensitive
17
Th(IV)
Yellow complex
measured
398
0.04–3.2
mg mL–1
NA pH dependent 18
Sodium
cobaltnitrite
and acetic acid
Product be-
tween DOX and
reagent in ace-
tic acid mea-
sured
243
0.01–0.03
mg mL–1
NA
heating, less
sensitive
19
Uranyl
acetate-DMF
medium
1:1 complex
between DOX
and uranyl
acetate in DMF
measured
405
0–135
mg mL–1
NA
organic solvent,
less sensitive
20
Cu(II)/H2O2
Decrease in
absorbance
measured
kinetically
510
2.97–17.78
mg mL–1
1.89/0.57
buffers, control
of experimental
variables, special
equipment
21
DMF/
NaOAc-AcOH
buffer (pH 4.5)
Partial
least-squares
multivariate
method applied
for a ternary
mixture
277–349
1.7–42
mg mL–1
NA
organic solvent,
pH dependent
22
F-C reagent/
Na2CO3
Blue colored
chromogen was
measured
770
0.75–12
mg mL–1
0.20/0.08
no heating
or extraction,
more sensitive
Present
work
NA – not available
CONCLUSIONS
A new sensitive spectrophotometric method has been developed, optimized and va-
lidated for the determination of doxycycline in bulk drug and in tablets. The simplicity,
sensitivity and selectivity make the method a suitable alternative to the HPLC methods.
Other characteristics such as short performance time, ease of handling and non-usage of
organic solvents, also suggest this procedure as a routine laboratory method. Therefore,
the proposed method can be adopted for the assay of DOX in quality control laborato-
ries where modern instruments are not available.
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S A @ E T A K
Osjetljivo i selektivno spektrofotometrijsko odre|ivanje doksiciklin hiklata
u farmaceutskim pripravcima koriste}i Folin-Ciocalteuov reagens
PAVAGADA JAGANNATHAMURTHY RAMESH, KANAKAPURA BASAVAIAH i NAGARAJU RAJENDRAPRASAD
U radu je opisana spektrofotometrijska metoda odre|ivanja doksiciklina (DOX).
DOX u bazi~nom mediju reducira volframat i/ili molibdat u Folin-Ciocalteuovom (F-C)
reagensu pri ~emu nastaje modro obojeni kromogen. Obojeni produkt ima apsorpcijski
maksimum pri 770 nm. Sustav podlije`e Beerovom zakonu u koncentracijskom podru-
~ju 0,7512,0 mg mL1 DOX. Molarni apsorpcijski koeficijent iznosi 2,78 ´ 104 L mol1
cm1. Granice kvantifikacije i detekcije su 0,20, odnosno 0,08 mg mL1. Unutar linearnog
podru~ja procijenjene su ispravnost i preciznost unutar jedne i vi{e eksperimentalnih se-
rija. Ispravnost je iznosila 101,0 ± 1,7 %, relativna pogre{ka  2,7 %, a relativna standard-
na devijacija  2,5 %. Ispitana je i primjenjivost predlo`ene metode na pra{kasti uzorak
doksiciklina i komercijalne tablete. Usporedbom rezultata dobivenih predlo`enom me-
todom i oficijelnom BP metodom nisu ustanovljene zna~ajne razlike. Opisana metoda je
jednostavna, brza, ispravna i precizna.
Klju~ne rije~i: doksiciklin hiklat, Folin-Ciocalteuov reagens, spektrofotometrija
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